Monashee Investment Management Reduces Stake in Structure Therapeutics
Monashee Investment Management reduced its stake in Structure Therapeutics (NASDAQ:GPCR) by $13.24 million during the first quarter of 2026, according to an SEC filing dated May 13, 2026. The firm now holds a remaining position representing just 1.8% of Monashee’s reportable assets under management.
Tickers: $GPCR
Topics: biotechnology clinical-stage_company portfolio changes SEC filing